10q10k10q10k.net

vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) and DIVERSIFIED HEALTHCARE TRUST (DHC), based on the latest 10-Q / 10-K filings. Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. /DE is the larger business by last-quarter revenue ($487.7M vs $379.6M, roughly 1.3× DIVERSIFIED HEALTHCARE TRUST). DIVERSIFIED HEALTHCARE TRUST runs the higher net margin — -10.1% vs -5.6%, a 4.5% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. /DE posted the faster year-over-year revenue change (44.7% vs -0.0%). DIVERSIFIED HEALTHCARE TRUST produced more free cash flow last quarter ($-52.5M vs $-68.7M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP. /DE's revenue compounded faster (18.6% CAGR vs 1.2%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

CLOV vs DHC — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.3× larger
CLOV
$487.7M
$379.6M
DHC
Growing faster (revenue YoY)
CLOV
CLOV
+44.7% gap
CLOV
44.7%
-0.0%
DHC
Higher net margin
DHC
DHC
4.5% more per $
DHC
-5.6%
-10.1%
CLOV
More free cash flow
DHC
DHC
$16.2M more FCF
DHC
$-52.5M
$-68.7M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
1.2%
DHC

Income Statement — Q4 2025 vs Q4 2025

Metric
CLOV
CLOV
DHC
DHC
Revenue
$487.7M
$379.6M
Net Profit
$-49.3M
$-21.2M
Gross Margin
Operating Margin
-10.1%
-12.6%
Net Margin
-10.1%
-5.6%
Revenue YoY
44.7%
-0.0%
Net Profit YoY
-123.2%
75.7%
EPS (diluted)
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align — see 8-quarter trend below.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history — bar widths are scaled to the larger of the two companies so you can eyeball the size gap and growth trajectory without doing math. Quarters aligned by calendar period (report date) so offset fiscal years line up.

Revenue
CLOV
CLOV
DHC
DHC
Q4 25
$487.7M
$379.6M
Q3 25
$496.6M
$388.7M
Q2 25
$477.6M
$382.7M
Q1 25
$462.3M
$386.9M
Q4 24
$337.0M
$379.6M
Q3 24
$331.0M
$373.6M
Q2 24
$356.3M
$371.4M
Q1 24
$346.9M
$370.8M
Net Profit
CLOV
CLOV
DHC
DHC
Q4 25
$-49.3M
$-21.2M
Q3 25
$-24.4M
$-164.0M
Q2 25
$-10.6M
$-91.6M
Q1 25
$-1.3M
$-9.0M
Q4 24
$-22.1M
$-87.4M
Q3 24
$-9.2M
$-98.7M
Q2 24
$7.4M
$-97.9M
Q1 24
$-19.2M
$-86.3M
Gross Margin
CLOV
CLOV
DHC
DHC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Q1 24
23.6%
Operating Margin
CLOV
CLOV
DHC
DHC
Q4 25
-10.1%
-12.6%
Q3 25
-4.9%
-43.4%
Q2 25
-2.2%
-24.5%
Q1 25
-0.3%
-2.7%
Q4 24
-6.4%
-26.1%
Q3 24
-2.7%
-26.5%
Q2 24
2.0%
-23.0%
Q1 24
-6.5%
-23.7%
Net Margin
CLOV
CLOV
DHC
DHC
Q4 25
-10.1%
-5.6%
Q3 25
-4.9%
-42.2%
Q2 25
-2.2%
-23.9%
Q1 25
-0.3%
-2.3%
Q4 24
-6.6%
-23.0%
Q3 24
-2.8%
-26.4%
Q2 24
2.1%
-26.3%
Q1 24
-5.5%
-23.3%
EPS (diluted)
CLOV
CLOV
DHC
DHC
Q4 25
$-0.09
Q3 25
$-0.68
Q2 25
$-0.38
Q1 25
$-0.04
Q4 24
$-0.37
Q3 24
$-0.41
Q2 24
$-0.41
Q1 24
$-0.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest filing — the kind of financial-strength check premium terminals charge for.

Metric
CLOV
CLOV
DHC
DHC
Cash + ST InvestmentsLiquidity on hand
$78.3M
$105.4M
Total DebtLower is stronger
$2.4B
Stockholders' EquityBook value
$308.7M
$1.7B
Total Assets
$541.0M
$4.4B
Debt / EquityLower = less leverage
1.47×

8-quarter trend — quarters aligned by calendar period so offset fiscal years match up.

Cash + ST Investments
CLOV
CLOV
DHC
DHC
Q4 25
$78.3M
$105.4M
Q3 25
$201.4M
Q2 25
$141.8M
Q1 25
$302.6M
Q4 24
$194.5M
$144.6M
Q3 24
$288.0M
$256.5M
Q2 24
$254.8M
$265.6M
Q1 24
$208.3M
$207.1M
Total Debt
CLOV
CLOV
DHC
DHC
Q4 25
$2.4B
Q3 25
Q2 25
Q1 25
Q4 24
$3.1B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CLOV
CLOV
DHC
DHC
Q4 25
$308.7M
$1.7B
Q3 25
$340.9M
$1.7B
Q2 25
$344.2M
$1.9B
Q1 25
$336.1M
$1.9B
Q4 24
$341.1M
$2.0B
Q3 24
$342.2M
$2.0B
Q2 24
$324.9M
$2.1B
Q1 24
$292.5M
$2.2B
Total Assets
CLOV
CLOV
DHC
DHC
Q4 25
$541.0M
$4.4B
Q3 25
$559.7M
$4.7B
Q2 25
$575.0M
$4.8B
Q1 25
$583.7M
$5.0B
Q4 24
$580.7M
$5.1B
Q3 24
$653.0M
$5.3B
Q2 24
$674.2M
$5.3B
Q1 24
$671.8M
$5.3B
Debt / Equity
CLOV
CLOV
DHC
DHC
Q4 25
1.47×
Q3 25
Q2 25
Q1 25
Q4 24
1.56×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Net income can be massaged; cash flow is harder to fake.

Metric
CLOV
CLOV
DHC
DHC
Operating Cash FlowLast quarter
$-68.2M
$-20.1M
Free Cash FlowOCF − Capex
$-68.7M
$-52.5M
FCF MarginFCF / Revenue
-14.1%
-13.8%
Capex IntensityCapex / Revenue; lower = less reinvestment burden
0.1%
8.5%
Cash ConversionOCF / Net Profit; >1× = earnings back up with cash
TTM Free Cash FlowTrailing 4 quarters
$-69.0M
$-166.4M

8-quarter trend — quarters aligned by calendar period so offset fiscal years match up.

Operating Cash Flow
CLOV
CLOV
DHC
DHC
Q4 25
$-68.2M
$-20.1M
Q3 25
$12.1M
$-49.3M
Q2 25
$5.4M
$53.0M
Q1 25
$-16.3M
$-3.2M
Q4 24
$-85.8M
$18.2M
Q3 24
$50.0M
$21.1M
Q2 24
$44.8M
$44.3M
Q1 24
$25.9M
$28.6M
Free Cash Flow
CLOV
CLOV
DHC
DHC
Q4 25
$-68.7M
$-52.5M
Q3 25
$11.4M
$-89.8M
Q2 25
$4.8M
$18.8M
Q1 25
$-16.5M
$-42.9M
Q4 24
$-86.1M
$-48.5M
Q3 24
$49.6M
$-26.1M
Q2 24
$44.4M
$3.3M
Q1 24
$25.5M
$-18.1M
FCF Margin
CLOV
CLOV
DHC
DHC
Q4 25
-14.1%
-13.8%
Q3 25
2.3%
-23.1%
Q2 25
1.0%
4.9%
Q1 25
-3.6%
-11.1%
Q4 24
-25.6%
-12.8%
Q3 24
15.0%
-7.0%
Q2 24
12.5%
0.9%
Q1 24
7.3%
-4.9%
Capex Intensity
CLOV
CLOV
DHC
DHC
Q4 25
0.1%
8.5%
Q3 25
0.1%
10.4%
Q2 25
0.1%
8.9%
Q1 25
0.0%
10.2%
Q4 24
0.1%
17.6%
Q3 24
0.1%
12.6%
Q2 24
0.1%
11.0%
Q1 24
0.1%
12.6%
Cash Conversion
CLOV
CLOV
DHC
DHC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
6.04×
Q1 24

Financial Flow Comparison

Sankey diagram of revenue → gross profit → operating profit → net profit for each company. Charts shown full-width and stacked so both segment hierarchies are readable side-by-side on desktop and mobile.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

DHC
DHC

Senior Housing Operating Portfolio Segment$323.4M85%
Rental Income$56.2M15%

Related Comparisons